Skip to main content
. 2000 Oct;38(10):3544–3549. doi: 10.1128/jcm.38.10.3544-3549.2000

TABLE 5.

Sensitivity of culturing and prevalence of infection at each test site

Group Sitea No. of specimens Asmptomatic
No. of specimens Symptomatic
%
%
Culture sensitivity Prevalence
Culture sensitivity Prevalence
Culturing Overall Culturing Overall
Women JHU 67 75.0 4.5 6.0 205 74.3 12.7 17.1
LSU 135 100.0 0.7 0.7 62 66.7 3.2 4.8
UTMB 24 50.0 8.3 16.7 112 85.7 5.4 6.3
IU 205 90.0 17.6 19.5 270 91.2 11.5 12.6
UCSF 227 100.0 0.9 0.9 236 100.0 2.1 2.1
TJUH 415 85.7 1.4 1.7 234 100.0 1.3 1.3
All 1,073 86.2 4.7 5.4 1,119 83.9 6.5 7.8
Men JHU 140 7.7b 0.7 9.3 439 85.7 28.7 33.5
LSU 164 60.0 1.8 3.0 31 85.7 38.7 45.2
UTMB 60 100.0 5.0 5.0 100 100.0 33.0 33.0
IU 290 100.0 1.7 1.7 517 98.1 30.4 30.9
UCSF 60 NAc <1.6 <1.6 180 94.4 9.4 10.0
All 714 46.2 1.7 3.6 1,267 92.7 27.2 29.4
a

JHU, Johns Hopkins University; LSU, Louisiana State University; UTMB, University of Texas Medical Branch at Galveston; IU, Indiana University; UCSF, University of California, San Francisco; TJUH, Thomas Jefferson University Hospital. 

b

COBAS AMPLICOR exhibited low sensitivity for asymptomatic men at JHU: 69.2% (9 of 13) and 15.4% (2 of 13) for urethral swab and urine specimens, respectively. Excluding JHU data, the overall sensitivities were 84.6% (11 of 13) for culturing and 76.9% (10 of 13) and 69.2% (9 of 13) for COBAS AMPLICOR with urethral swab and urine specimens, respectively. 

c

NA, none of the 60 individuals was infected with N. gonorrhoeae